Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation

@article{Vistoli2013AdvancedGA,
  title={Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation},
  author={G. Vistoli and D. De Maddis and A. {\vC}ipak and N. Žarkovi{\'c} and M. Carini and G. Aldini},
  journal={Free Radical Research},
  year={2013},
  volume={47},
  pages={27 - 3}
}
Abstract Advanced lipoxidation end products (ALEs) and advanced glycation end products (AGEs) have a pathogenetic role in the development and progression of different oxidative-based diseases including diabetes, atherosclerosis, and neurological disorders. AGEs and ALEs represent a quite complex class of compounds that are formed by different mechanisms, by heterogeneous precursors and that can be formed either exogenously or endogenously. There is a wide interest in AGEs and ALEs involving… Expand
376 Citations
Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why
  • 13
  • PDF
Polyphenols and AGEs/RAGE axis. Trends and challenges.
  • 6
Advanced Glycation End Products and Their Involvement in Cardiovascular Disease
  • 1
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 454 REFERENCES
An update on advanced glycation endproducts and atherosclerosis
  • 87
Dietary Advanced Glycation End Products and Aging
  • 214
  • PDF
The road to advanced glycation end products: a mechanistic perspective.
  • 140
Clinical review: The role of advanced glycation end products in progression and complications of diabetes.
  • S. Goh, M. Cooper
  • Medicine
  • The Journal of clinical endocrinology and metabolism
  • 2008
  • 801
  • PDF
Dietary advanced glycation endproducts (AGEs) and their health effects--PRO.
  • 133
Chemical Modification of Proteins by Lipids in Diabetes
  • J. Baynes
  • Chemistry, Medicine
  • Clinical chemistry and laboratory medicine
  • 2003
  • 67
Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective
  • 191
...
1
2
3
4
5
...